ROCHE FDA Approval NDA 006917

NDA 006917

ROCHE

FDA Drug Application

Application #006917

Application Sponsors

NDA 006917ROCHE

Marketing Status

Discontinued001

Application Products

001INJECTABLE;INJECTIONEQ 400MG BASE/ML0GANTRISINSULFISOXAZOLE DIOLAMINE

CDER Filings

ROCHE
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 6917
            [companyName] => ROCHE
            [docInserts] => ["",""]
            [products] => [{"drugName":"GANTRISIN","activeIngredients":"SULFISOXAZOLE DIOLAMINE","strength":"EQ 400MG BASE\/ML","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"GANTRISIN","submission":"SULFISOXAZOLE DIOLAMINE","actionType":"EQ 400MG BASE\/ML","submissionClassification":"INJECTABLE;INJECTION","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.